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• Review the current situation and the advances 
produced in arthropod’s immunological control  
 
•  Analyze the reasons which have limited this kind 
of vaccines 
The importance that arthropod parasites have in veterinarian 
science is based on its capacity to harm animals. Not only for its 
direct actions on the host but also for the transmission of some 
pathogens. A variety of measures have been used historically and 
are currently  used to control this parasites. 
OBJECTIVES INTRODUCTION 
A VACCINE AGAINST ARTHROPODS? 
Two approaches to vaccination 
• Exploitation of the antigens of naturally acquired immunity 
• Vaccination against ‘concealed’ antigens  
 
TICKS    MITES  MYIASIS  FLEAS  MOSQUITOES 
IDEAL ANTIGEN FOR VACCINES 
EASILY ACCESSIBLE TO THE HOST IMMUNE 
EFFECTORS 
 
CRITICAL FUNCTION 
 
SHARE CONSERVED EPITOPES AMONG 
OTHER ARTHROPOD VECTORS 
 
REDUCE THE VECTOR CAPACITY FOR THE 
TRANSMISSION OF VECTOR-BORNE 
PATHOGENS 
 
PROTEIN/ANTIGEN 
 
Bm86 
 
Bm95 
 
Bm91 
 
P29 
 
 
TICK SPECIES 
 
Rhipicephalus microplus 
 
Rhipicephalus microplus 
 
 
Rhipicephalus microplus 
 
 
Haemaphysalis longicornis 
Table 1. Recombinant proteins used in vaccines against ticks 
• Reduction of tick infestations on cattle 
• Increased animal production 
• Decreased incidence of anaplasmosis and 
babesiosis 
• Reduction in the use of acaricides 
 
TICK SPECIES                         CROSS-PROTECTION 
 
Rhipicephalus  annulatus 
 
Rhipicephalus decoloratus 
 
Rhipicephalus appendiculatus 
 
Amblyomma variegatum 
 
Hyalomma anatolicum 
 
Hyalomma dromedarii  
Table 2. Crossed-protection for Bm86  (Rhipicephalus microplus) against 
different species of ticks 
Figure 1. The reduction of the acaricide consumption in Cuba before 
1986 and after implementation of the integrated control program in 
1995 against R. microplus (Rodríguez et al., 2004) 
CONCLUSION 
PROBLEMS 
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• Lack of research and difficulties in  
identify effective antigens 
• Immune responses 
• Variety of arthropods 
• Acaricides and insecticides 
• Development, manufacturing, registration 
and commercialization of a vaccine is a 
long and expensive process 
 
Immunological control would mean a great scientific advance, however 
vaccination against arthropods continues being an expectation. It is 
necessary to overcome all problems to get this control. It's required, 
therefore, more research in this field and developing new technologies 
to find new antigenic targets. A future trends of research are 
multicomponent vaccines or vaccines against multiple arthropods. 
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